KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Asset Utilization Ratio (2019 - 2025)

Esperion Therapeutics (ESPR) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.97 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio fell 3.83% year-over-year to 0.97, compared with a TTM value of 0.97 through Dec 2025, down 3.83%, and an annual FY2025 reading of 1.0, down 17.66% over the prior year.
  • Asset Utilization Ratio was 0.97 for Q4 2025 at Esperion Therapeutics, up from 0.85 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.01 in Q4 2024 and bottomed at 0.21 in Q2 2022.
  • Average Asset Utilization Ratio over 5 years is 0.55, with a median of 0.5 recorded in 2023.
  • Peak annual rise in Asset Utilization Ratio hit 2945.93% in 2021, while the deepest fall reached 73.77% in 2021.
  • Year by year, Asset Utilization Ratio stood at 0.26 in 2021, then rose by 4.12% to 0.27 in 2022, then soared by 102.37% to 0.54 in 2023, then surged by 85.43% to 1.01 in 2024, then decreased by 3.83% to 0.97 in 2025.
  • Business Quant data shows Asset Utilization Ratio for ESPR at 0.97 in Q4 2025, 0.85 in Q3 2025, and 0.8 in Q2 2025.